01—Abstract
Summary
Summary of the 8-K filed July 7, 2025. Cited figures are marked; the original filing is the authoritative source.
On July 7, 2025, Bunge Global SA (NYSE: BG) announced the expiration and final results of exchange offers and consent solicitations run by its wholly-owned subsidiary, Bunge Limited Finance Corp. (BLFC), for four series of notes originally issued by Viterra Finance B.V.
(2.000% due 2026, 4.900% due 2027, 3.200% due 2031 and 5.250% due 2032). The exchange offers expired July 3, 2025, and holders tendered 96.6% to 99.9% of each series, with the 2026 notes at 96.63%, the 2027 notes at 97.72%, the 2031 notes at 99.77% and the 2032 notes at 99.93%. Holders exchanged into new Bunge-guaranteed notes of up to $1.95 billiona in aggregate principal, plus cash.
The transaction is a consequence of Bunge's completed acquisition of Viterra, which closed on July 2, 2025 and was a condition of the offers. The consents already received in September 2024 authorize amendments that strip most covenants, restrictive provisions and events of default from the legacy Viterra notes, and release the parent guarantees of Viterra Limited and Viterra B.V. These amendments become operative only at settlement, which is expected on July 8, 2025.
Once settled, the remaining legacy Viterra debt will be effectively consolidated into Bunge's own credit structure, with Bunge as the guarantor of the new notes and the Viterra guarantees removed. For investors, the filing is primarily a debt-refinancing and simplification event rather than a change in operating results. The very high participation rates indicate broad holder acceptance of the exchange terms, which reduces the legacy Viterra debt stack and its separate guarantee structure.
The principal risks lie in execution and in the ultimate size of the new Bunge-guaranteed obligations, which add to Bunge's consolidated debt load. The filing does not disclose updated financial results or guidance, so the assessment depends on Bunge's broader leverage and cash flow profile after the Viterra integration.
02—Key points
Key Highlights
- Bunge completed its acquisition of Viterra on July 2, 2025, and all conditions of the exchange offers and consent solicitations were satisfied.
- The exchange offers expired July 3, 2025 with very high participation: 96.63% of the 2026 notes, 97.72% of the 2027 notes, 99.77% of the 2031 notes and 99.93% of the 2032 notes were tendered.
- Tendering holders receive up to $1.95 billion aggregate principal of new Bunge Limited Finance Corp. notes guaranteed by Bunge Global SA, plus cash.
- Consents from September 2024 approved amendments that remove most covenants, restrictive provisions and events of default from the legacy Viterra notes.
- The amendments also release the guarantees previously provided by Viterra Limited and Viterra B.V., simplifying the capital structure under Bunge's parent.
- Settlement of the exchange offers and consent solicitations is expected on July 8, 2025, at which point the supplemental indentures become operative.
- The new notes have not been registered under the Securities Act and may only be offered or sold under an applicable exemption.
03—Questions
Frequently Asked Questions
What did Bunge announce in this 8-K?
Bunge announced the expiration and final results of exchange offers and consent solicitations run by its subsidiary Bunge Limited Finance Corp. for four series of Viterra-issued notes. Holders could exchange those notes for new Bunge-guaranteed notes of up to $1.95 billion in principal, plus cash. The offers expired July 3, 2025, and settlement is expected July 8, 2025.
Why did holders tender such a large share of the notes?
The consents delivered in September 2024 were sufficient to approve the amendments, and the exchange offers gave holders a path into new Bunge-guaranteed debt. Tender rates ranged from 96.63% to 99.93% across the four series, which indicates that holders accepted the exchange terms and the removal of the legacy covenants and Viterra guarantees.
Does this transaction change Bunge's financial results or guidance?
No. The filing discloses no updated financial results, guidance or operating metrics. It is a debt exchange and structural simplification that follows the completed Viterra acquisition. Its effect on Bunge's leverage and cash flows must be assessed using Bunge's other filings, particularly its 10-K and 10-Q.
How much of the legacy Viterra debt remains outstanding after the exchange?
The filing does not state the remaining amount after settlement. It reports the tendered principal for each series: $579.8 million of the $600 million 2026 notes, $439.7 million of the $450 million 2027 notes, $598.6 million of the $600 million 2031 notes and $299.8 million of the $300 million 2032 notes. The untendered balances are small relative to the total, but the exact residual amounts must be confirmed in the final settlement disclosures.
What risks should investors consider?
Key risks include the execution of the settlement on the expected date, the addition of up to $1.95 billion of Bunge-guaranteed debt to the consolidated obligations, and the cautionary items in the forward-looking statements, including Bunge's ability to generate sufficient cash flow to service debt and to access capital. The new notes are unregistered, which limits their resale until an exemption applies.
04—Continue